iShares Trust iShares Neuroscience and Healthcare ETF
BlackRock, Inc. IBRN ETF
IBRN Price | $21.4577 |
Market Cap | $3.48M |
Annual Dividend Yield | 0.45% |
Annual Dividend | $0.10 |
Yearly Management Fee | 0.47% |
Asset Class | Equity |
Focus | Health care |
Category | Sector, Health Care |
Niche | Pharma, biotech & life sciences |
Last 24h Volume | $880 |
Portfolio Management Company | BlackRock, Inc. |
Discount/Premium to NAV | -0.04% |
Inception Date | Aug 24, 2022 |
Market Cap Rank | 3816 |
Monthly AUM Growth | -6.98% |
Holdings Region | Global |
Management Style | Passive |
Leverage | Non-Leveraged |
iShares Trust iShares Neuroscience and Healthcare ETF is an ETF issued by BlackRock, Inc. on Aug 24 2022.
The main focus of this ETF, which is in the "Equity" asset class, is determined as "Health care".
As of today, the price of IBRN ETF according to its net asset value is discounted at -0.04%.
While the total value of the fund shows $-260,595 decrease compared to the previous month, its price is traded daily at a decrease of -3.97%.
The annual dividend yield of IBRN ETF is 0.45%, whereas its main asset area is Global.
IBRN ETF, whose 24-hour total volume is $880, has experienced a $0 cash outflow in the last month.
In addition, iShares Trust iShares Neuroscience and Healthcare ETF's net asset value total return is 0.00%.
IBRN ETF Returns
Daily |
Weekly |
Monthly |
3 Mo |
6 Mo |
YTD |
Yearly |
-3.97% |
-9.69% |
-12.67% |
-15.53% |
-13.44% |
-17.14% |
-15.12% |
IBRN ETF NAV Total Return
Monthly |
3 Mo |
YTD |
Yearly |
3 Years |
5 Years |
-10.24% |
-13.62% |
-12.15% |
-12.31% |
-12.15% |
-12.15% |
IBRN ETF Fund Flows Chart
IBRN ETF Market Cap Chart
IBRN ETF NAV Growth Chart
IBRN ETF Comments
no comments yet